Authors
Kensuke Shoji, Takayuki Akiyama, Shinya Tsuzuki, Nobuaki Matsunaga, Yusuke Asai, Setsuko Suzuki, Noriko Iwamoto, Takanori Funaki, Norio Ohmagari
Publication date
2022/11/1
Journal
Journal of Infection and Chemotherapy
Volume
28
Issue
11
Pages
1531-1535
Publisher
Elsevier
Description
Introduction
Information regarding the clinical manifestations and outcomes of coronavirus disease 2019 (COVID-19) in children under the Omicron variant predominant period is still limited.
Methods
A nationwide retrospective cohort study was conducted. Pediatric COVID-19 patients (<18 years of age) hospitalized between August 1, 2021 and March 31, 2022 were enrolled. Epidemiological and clinical characteristics between the Delta variant predominant period (August 1 to December 31, 2021) and the Omicron variant predominant period (January 1 to March 31, 2022) were compared.
Results
During the study period, 458 cases in the Delta predominant period and 389 cases in the Omicron predominant period were identified. Median age was younger (6.0 vs. 8.0 years, P = 0.004) and underlying diseases were more common (n = 65, 16.7% vs. n = 53, 11.6%) in the Omicron predominant period than those in the …
Total citations
20222023202443210
Scholar articles
K Shoji, T Akiyama, S Tsuzuki, N Matsunaga, Y Asai… - Journal of Infection and Chemotherapy, 2022